Ardent Health, Inc.
ARDTHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeArdent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company carries a $1.52B market cap, placing it firmly in the small-cap category. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings.
Market Cap
$1.52B
Beta
0.70
P/E (TTM)
19.91
P/E (Fwd)
8.57
EPS (TTM)
$0.54
EPS (Fwd)
$1.25
ROE
10.0%
ROA
3.1%
Cash
$724.5M
Total Debt
$2.27B
Free CF
$208.3M
52W Change
-16.3%
Annual Financials
Cash vs Debt
Where ARDT stands vs its 150-day and 200-day moving averages
As of the August 17, 2026 close, ARDT finished 14.36% above its 150-day moving average ($9.54) and 12.36% above its 200-day moving average ($9.71). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ARDT overbought or oversold?
At the August 17, 2026 close, ARDT's RSI(14) was 49.4, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $724.5M in cash, though total debt stands at $2.27B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $208.3M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 10.0% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.1% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $5.13B (2022) to $6.32B (2025), reflecting a 23% increase over the period.
As with any equity investment, ARDT carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. No single metric tells the full story. Reviewing ARDT's risk profile alongside its fundamentals and technical indicators provides a more complete picture.